NEW
YORK, July 31, 2024 /PRNewswire/ -- The global
cell surface markers market size is estimated to grow by
USD 14.07 billion from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of 8.25% during the forecast period. COVID-19 pandemic
impact is driving market growth, with a trend
towards increased use of diagnostics in cancer detection.
However, high cost of instruments related to cell surface
markers poses a challenge. Key market players include Abbott
Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories
Inc., Bio Techne Corp., Cell Signaling Technology Inc., Danaher
Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GenScript Biotech
Corp., Grifols SA, IVD Medical Holding Ltd., Johnson and Johnson,
PerkinElmer Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp.,
Thermo Fisher Scientific Inc., and Werfenlife SA.
![Technavio has announced its latest market research report titled Global Cell Surface Markers Market 2024-2028 Technavio has announced its latest market research report titled Global Cell Surface Markers Market 2024-2028](https://mma.prnewswire.com/media/2471819/Technavio_Global_Cell_Surface_Markers.jpg)
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Application (Disease
diagnosis, Research, and drug discovery), Product (Antibody and PCR
array), and Geography (North America, Europe, Asia, and Rest of
World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Abbott Laboratories,
Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio
Rad Laboratories Inc., Bio Techne Corp., Cell Signaling Technology
Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd.,
GenScript Biotech Corp., Grifols SA, IVD Medical Holding Ltd.,
Johnson and Johnson, PerkinElmer Inc., QIAGEN NV, Siemens
Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and
Werfenlife SA
|
Key Market Trends Fueling Growth
The cell surface markers market is experiencing growth due to
their application in diagnostic methods for detecting cancer cells.
With an estimated 19.3 million new cancer cases and 10 million
cancer deaths reported in 2020, according to Globocan 2020, the
demand for biomarkers is expected to rise. Cell surface markers
function as identifiers for specific cell types by attaching to
proteins on their surface. This identification process is crucial
for cancer diagnosis, targeted therapy, drug research, and other
applications. As a result, the global cell surface marker market is
projected to expand significantly throughout the forecast
period.
The Cell Surface Markers market is witnessing significant growth
due to increasing research activities in the fields of Mice and
Rats for understanding Host-Pathogen interactions and inflammatory
diseases. Antibodies are key players in identifying specific cell
types and populations, driving demand in research applications and
clinical diagnostics. In vitro diagnostics firms like Sysmex Europe
SE and Diatron are investing in advanced technologies like the
Aquarius 3 for high-content screening. Funding from financial
markets and economic growth in the pharmaceutical industry are
boosting drug development. Journal Molecular and Cellular Pathology
and Journal Biomedicines publish research on cell surface antigens
and proteins as identification tags for therapeutic targeting and
personalized medicine. Signaling heterogeneity and organelle
targets are emerging trends. Immune responses and disease severity
are crucial factors influencing market growth. Cell analysis
techniques are expanding applications in medical research and
clinical diagnostics.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- Clinical laboratories and hospitals face operational
sustainability concerns, making them cautious about investing in
expensive cell surface marker analysis instruments. The high cost
of sophisticated devices like flow cytometers and hematology
analyzers, coupled with regulatory and reimbursement uncertainties,
limit the entry of small clinical laboratories and hospitals into
this market. Small pharmaceutical companies also hesitate to invest
due to unclear cost-benefit ratios, as drug development expenses
are already substantial. This reluctance from small players hampers
the growth of the global cell surface markers market during the
forecast period.
- The Cell Surface Markers Market faces challenges in various
sectors including oncology, immunology, stem cell research, and
infectious diseases. The market requires advanced cell analysis
instruments like flow cytometers and hematology analyzers for
research in these areas. Technological advancements, such as
high-speed multiparametric analysis and development of multiplexed
analysis platforms, are crucial for progress. Pharmaceutical
industries and healthcare infrastructure invest heavily in research
drug discovery, utilizing flow cytometry for detection and labeling
in cancer, autoimmune disorders, and hematological disorders.
Precision medicine and personalized therapies are driving market
growth. However, intense competition among established players and
emerging companies, favorable government initiatives, supportive
reimbursement policies, and a robust regulatory framework are
essential for market success. The market is highly fragmented, with
a focus on chronic diseases like cardiovascular diseases.
Collaborations and product portfolios are key market positioning
strategies. Reagents and kits are essential for research, while
advanced technologies and prevalence of cancer further fuel market
demand.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This cell surface markers market report extensively covers
market segmentation by
- Application
- 1.1 Disease diagnosis
- 1.2 Research
- 1.3 drug discovery
- Product
- 2.1 Antibody
- 2.2 PCR array
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Disease diagnosis- Cell surface markers, also known
as cell surface proteins, play a crucial role in identifying and
classifying various cells due to their specific biological
functions. In immunology, these markers are essential for efficient
disease diagnosis, sample preparation, drug discovery, and
treatment determination through immunophenotyping. The increasing
adoption of in-vitro diagnostics (IVD) is driving market growth.
IVD includes diagnostic test products, instruments, and supplies,
which focus on identifying conditions outside the body with ease
and speed. The rising prevalence of chronic diseases, such as
cancer and cardiovascular disease, and the need for accurate and
early disease detection have boosted the demand for IVDs. Advanced
flow cytometers and high-quality antibodies facilitate rapid
disease diagnosis and efficient drug discovery, fueling the growth
of the global cell surface markers market in the disease diagnosis
segment.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data (2018 -
2022) - Download a Sample Report
Research Analysis
Cell surface markers, also known as cell surface antigens, are
proteins and molecules that act as identification tags on the
exterior of cells. In the life sciences, they play a crucial role
in medical research, diagnostics, and drug development. These
markers are essential for the identification and differentiation of
various cell types, including those involved in host-pathogen
interactions, inflammatory diseases, and cancer. In research
applications, they are used extensively in life sciences solutions,
laboratories, and in vitro diagnostics. The prevalence of cancer
and other diseases has led to an increased focus on cell surface
markers in medical research. Mice and rats are commonly used in
studies due to their genetic similarities to humans. Antibodies are
frequently used to detect and isolate cell surface markers, and
funding for research in this area continues to grow. Overall, cell
surface markers are invaluable tools in the field of life sciences,
contributing to a better understanding of various diseases and
potential therapeutic targets.
Market Research Overview
The Cell Surface Markers Market encompasses the use of cell
surface antigens, proteins, and molecules as identification tags
for specific cell types and populations in various fields of
medical research. These markers play a crucial role in disease
mechanisms, therapeutic targeting, and personalized medicine.
Applications span across oncology, immunology, stem cell research,
and infectious diseases. Cell analysis techniques, such as flow
cytometry and hematology analyzers, are expanding in applications,
driven by technological advancements and the development of
multiplexed analysis platforms. Pharmaceutical industries and
clinical diagnostics utilize these tools for research drug
discovery, detection and labeling, and monitoring of diseases. The
market is highly fragmented, with intense competition among
established players and emerging companies. Favorable government
initiatives, supportive reimbursement policies, and a robust
regulatory framework foster market growth. Applications extend to
chronic diseases like cancer, cardiovascular diseases, and
autoimmune disorders. The market's size is influenced by the
prevalence of diseases, economic factors, and the financial
markets. Publications in journals like Molecular Cellular
Pathology, Journal Biomedicines, and High-content screening provide
insights into the latest research and developments. The market also
includes the use of animals like Mice and Rats, antibodies,
research applications, clinical applications, laboratories, in
vitro diagnostics, funding, host-pathogen interactions,
inflammatory diseases, organelle targets, signaling heterogeneity,
economy, drugs, firms, and financial markets.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Application
-
- Disease Diagnosis
- Research
- Drug Discovery
- Product
-
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cell-surface-markers-market-size-is-set-to-grow-by-usd-14-07-billion-from-2024-2028--covid-19-pandemic-impact-to-boost-the-market-growth-technavio-302210048.html
SOURCE Technavio